Board-certified in the United States and Canada, Dr. Patel is an associate professor of ophthalmology and director of the Neuro-Ophthalmology and Adult Strabismus Program at the USC Roski Eye Institute, Keck School of Medicine. He also serves as the Residency Program director and Neuro-Ophthalmology Fellowship director at USC. He is currently a board examiner for the Royal College of Physicians and Surgeons of Canada. He is a co-editor of Walsh and Hoyt’s Clinical Neuro-Ophthalmology: The Essentials, 3rd Edition, which is widely recognized as one of the pre-eminent textbooks in the field.
Dr. Patel has considerable expertise and experience in the surgical management of complex adult strabismus including the use of adjustable sutures and transposition techniques.
Dr. Patel’s major academic interest is in the study and imaging of the visual pathways. He has considerable expertise and experience in interpreting visual fields, microperimetry, and optical coherence tomography scans, in addition to the clinical evaluation and identification of patients with visual loss due to optic neuropathies and intracranial disorders. Dr. Patel is a co-investigator on a multidisciplinary collaboration involving ultra-high resolution imaging of the visual pathways and how they are affected in various optic nerve and retinal disorders.
USC Roski Eye Institute: Faculty Teacher of the Year, 2015
University of Ottawa Eye Institute: Faculty Teacher of the Year, 2009
Department of Ophthalmology, University of Wisconsin: Faculty Teacher of the Year, 2008
Department of Ophthalmology, University of Southern California: Faculty Teacher of the Year, 2007
McGill University, Department of Ophthalmology: Leadership Award, 2006
Canadian Space Agency (in conjunction with NASA): Aerospace Medicine Award, 2002
University of Saskatchewan: Top Graduating Student in Neurology, 2001
p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cellsJ Thorac Cardiovasc Surg. 2018 Aug; 156(2):556-565. e1. . View in PubMed
p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells J Thorac Cardiovasc Surg. 2018 Apr 13. . View in PubMed
The printed trachea J Thorac Dis. 2017 Oct; 9(10):3672-3673. . View in PubMed
In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regenerationJ Thorac Cardiovasc Surg. 2017 Feb; 153(2):329-339. e3. . View in PubMed
Less may be more: Using small molecules to reprogram human cells into functional cardiomyocytes J Thorac Cardiovasc Surg. 2017 Jan; 153(1):128-130. . View in PubMed
MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1 J Am Heart Assoc. 2016 Nov 10; 5(11). . View in PubMed
Direct Cardiac Cellular Reprogramming for Cardiac Regeneration Curr Treat Options Cardiovasc Med. 2016 Sep; 18(9):58. . View in PubMed
MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1 J Am Heart Assoc. 2016 11 10; 5(11). . View in PubMed